Searched for
ANTINEOPLASTICS GROWTH
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 27%As the market seems to be in comeback mode, it helps to be aware that the best (and probably biggest) wealth creator of the last couple of ...- These large- and mid-cap stocks may give more than 25% return in 1 year, according to analystsFor the last few earnings seasons, the message has been: “Show me growth, I have the money.” Stocks with better-than-expected earnings saw ...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- Stock picks of the week: 6 stocks with consistent score improvement and upside potential of up to 29%Usually, official talks are mere formalities – meetings to ink things that have already been agreed upon. The one scheduled between the US ...
- Time to increase the risk quotient? Maybe, but selectively: 5 large-caps from different sectors with upside potential of up to 28%With Israel refusing to play ball and Iran maintaining its vice-like hold on the Strait of Hormuz, the ceasefire declared by US President T...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 29%The market is again abuzz with the possibility of peace in the Gulf. This has, however, happened in the past. There is, thus, no point in g...
- In times of war and volatility – A better ratio for long-term investing: 5 stocks with the right PEG ratioThere is only one certainty in terms of the escalating war in the Gulf region: Global markets are going to remain roiled for the foreseeabl...
- For investor with a 2-3 year perspective: 5 stocks from 3 sectors with an upside potential of up to 39%Consider this. A company has implemented a restructuring plan and the numbers are showing a positive impact. So, should a decline in the st...
- Pharma: Stay bullish, but hedge to avoid mistake of selling due to deadline. 7 stocks with upside potential of up to 50%While Democrats are better known to push for lower drug prices in the US, in recent times even Republicans are talking about keeping the co...
- Recovery time? Be selective, stay diversified and use this ratio for better decisions. 5 stocks with the right ratio and sales growthHow do you value a stock? Which has a high valuation, which is cheap? It depends on the ratio you use to ascertain value. And relying entir...
- Why this important ratio will help in better stock-picking. 7 stocks from different sectors which fit the bill of this less-used ratioThere is always the chance of going wrong in the market. So, caution and a long-term perspective should be your watchwords. But there are t...
- Pharma market picks up pace, sees 10% value growth in NovIndia's pharmaceutical market rebounded in November with 9.9% value growth and 3.1% volume growth. Key therapy areas like cardiac, gastroin...
- As smog engulfs the street, essential pills for a healthy of portfolio: 5 pharma stocks with an upside potential of up to 39%Here’s a lesson from history: For a long-term investor, buying in a correcting market is mostly an opportunity. The operative part, of cour...
- Better use this ratio to avoid value traps: 5 stocks with the right PEG ratio and an upside potential of up to 39%Given the events of the past week – and expected global cues – the markets are likely to remain volatile for a while and even see some corr...
- Corrections are opportunities, if you enter the right sector and stocks: 5 stocks from pharma sector with an upside potential of up to 32%At a time when the Nifty and Sensex are trading with cuts in excess of 1%, talking of buying stocks may not appear quite right. But correct...
- Drug sales get a monsoon twist in AugustLiver herbal supplement Liv 52 emerged as one of India's top-selling herbal tonics in August, driven by increased cases of liver-related il...
- Volatile phases come and go, structural tailwinds are a stronger play: 5 Indian pharma stocks with upside potential of up to 35%There are some sectors which have witnessed something which can be called “second inning”. Which is that in the last two decades, they did ...
- Pharma market grows 9% in Feb on price increase, new productsIndia's pharmaceutical market witnessed a robust 9% month-on-month growth in February, driven by strong performance in cardiology and anti-...
- Pharma market grows 9.5% in JanuaryThe Indian pharmaceutical market (IPM) saw a robust growth of 9.5% in January with all major therapy areas recording double-digit growth. A...
- Pharma growth shrinks to 4.5% in June as Covid-led segments show decrease in salesIndia's pharmaceutical market contracted by 4.5% in June due to a fall in anti-infectives and respiratory drug sales as Covid cases decreas...
Load More
